|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||2.0850 - 2.4000|
|52 Week Range||2.0500 - 10.5300|
|Beta (5Y Monthly)||0.72|
|PE Ratio (TTM)||0.56|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Jun 15, 2021|
|1y Target Est||N/A|
New York, New York--(Newsfile Corp. - October 22, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of China Evergrande Group (OTC Pink: EGRNF) (OTC Pink: EGRNY) resulting from allegations that China Evergrande may have issued materially misleading business information to the investing public.SO WHAT: If you purchased China Evergrande securities you may be entitled to compensation without payment of ...
NEW YORK, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of China Evergrande Group (“China Evergrande” or the “Company”) (OTCMKTS: EGRNY; EGRNF). Such investors are advised to contact Robert S. Willoughby at email@example.com or 888-476-6529, ext. 7980. The investigation concerns whether China Evergrande and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information
NEW YORK, October 05, 2021--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against China Evergrande Group ("China Evergrande" or the "Company") (Other OTC: EGRNY) on behalf of China Evergrande stockholders. Our investigation concerns whether China Evergrande has violated the federal securities laws and/or engaged in other unlawful business practices.